网站大量收购独家精品文档,联系QQ:2885784924

老年房颤患者抗凝治疗的安全性策略(2018年版).pptVIP

老年房颤患者抗凝治疗的安全性策略(2018年版).ppt

  1. 1、本文档共49页,可阅读全部内容。
  2. 2、有哪些信誉好的足球投注网站(book118)网站文档一经付费(服务费),不意味着购买了该文档的版权,仅供个人/单位学习、研究之用,不得用于商业用途,未经授权,严禁复制、发行、汇编、翻译或者网络传播等,侵权必究。
  3. 3、本站所有内容均由合作方或网友上传,本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺!文档内容仅供研究参考,付费前请自行鉴别。如您付费,意味着您自己接受本站规则且自行承担风险,本站不退款、不进行额外附加服务;查看《如何避免下载的几个坑》。如果您已付费下载过本站文档,您可以点击 这里二次下载
  4. 4、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等,请点击“版权申诉”(推荐),也可以打举报电话:400-050-0827(电话支持时间:9:00-18:30)。
  5. 5、该文档为VIP文档,如果想要下载,成为VIP会员后,下载免费。
  6. 6、成为VIP后,下载本文档将扣除1次下载权益。下载后,不支持退款、换文档。如有疑问请联系我们
  7. 7、成为VIP后,您将拥有八大权益,权益包括:VIP文档下载权益、阅读免打扰、文档格式转换、高级专利检索、专属身份标志、高级客服、多端互通、版权登记。
  8. 8、VIP文档为合作方或网友上传,每下载1次, 网站将根据用户上传文档的质量评分、类型等,对文档贡献者给予高额补贴、流量扶持。如果你也想贡献VIP文档。上传文档
查看更多
Cumulative survival (%) during the 12-month follow-up of patients with newly diagnosed acute ischemic stroke without (n=6270) and with (n=642) atrial fibrillation Ischemic stroke associated with AF is typically more severe than stroke due to other etiologies This study assessed whether the severity of acute ischemic stroke associated with AF is worse than ischemic stroke associated with other causes A bedridden state was used as an indicator of stroke severity The frequency of bedridden state was 41.2% in stroke patients with AF, compared to 23.7% in patients without AF (P 0.0005) Significantly more Acute Ischemic Stroke patients with AF compared to without were in the bedridden state The odds ratio for bedridden state following ischemic stroke due to AF was 2.23 Reference: Dulli DA, et al. Atrial fibrillation is associated with severe acute ischemic stroke. Neuroepidemiology. 2003;22(2):118-23 * 我国有近800万房颤患者,进行抗栓治疗的不足10%,远低于世界平均水平。在此背景下,中国心脏健康教育联盟(A-A China)与世界同步开展“2014心脏教育周”活动,主题是“关注心房颤,远离脑卒中”,旨在让公众关注房颤脑卒中危险性和抗凝的重要性。6月5日-10日一周,在全国6个省市同步开展。 * 仍然沿用高中低危的危险分层,主要不同是对中高危患者的抗凝管理都给出利伐沙班和达比加群的治疗推荐。 UK: NICE guidance 2006 and 2012 Key priorities for implementation: Antithrombotic therapy In patients with newly diagnosed AF for whom antithrombotic therapy is indicated, such treatment should be initiated with minimal delay after the appropriate management of co-morbidities For patients at intermediate risk: Owing to lack of sufficient clear-cut evidence, treatment may be decided on an individual basis, and the physician must balance the risk and benefits of warfarin versus ASA. As stroke risk factors are cumulative, warfarin may, for example, be used in the presence of 2 or more moderate stroke risk factors This scheme was updated by Lip et al. in 2009 to include newly recognized risk factors such as female gender, and expressed as the cumulative point-based scheme CHA2DS2-VASc2 New NICE recommendations were made on dabigatran in March 2012 and on rivaroxaban in May 201

文档评论(0)

peace0308 + 关注
实名认证
文档贡献者

该用户很懒,什么也没介绍

1亿VIP精品文档

相关文档